Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-me
about
FJU-C4, a new 2-pyridone compound, attenuates lipopolysaccharide-induced systemic inflammation via p38MAPK and NF-κB in miceIL-17A Monoclonal Antibody Partly Reverses the Glucocorticoids Insensitivity in Mice Exposed to Ozonec.Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke.Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism.Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory.Evaluation of glucocorticoid receptor function in COPD lung macrophages using beclomethasone-17-monopropionate.Lung inflammation changes and oxidative stress induced by cigarette smoke exposure in guinea pigs affected by Zataria multiflora and its constituent, carvacrol.Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitorRoflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.Small molecule kinase inhibitors block the ZAK-dependent inflammatory effects of doxorubicin.Cutting Edge: CLEC5A Mediates Macrophage Function and Chronic Obstructive Pulmonary Disease PathologiesCharacterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD.Characterisation of lung macrophage subpopulations in COPD patients and controls.Effect of the Zataria multiflora on systemic inflammation of experimental animals model of COPD.A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients.p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function.Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages.Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cells.
P2860
Q28537893-F1FC22F1-46DB-45BB-A9E5-E9BB4D948ED3Q33676504-2FF33A82-49D1-4044-86E0-63D3338AAEF2Q33774669-B4699687-2F4A-4443-8513-E05135ED5D4BQ34475700-E083F412-34FE-406B-BAC3-198F5DC34204Q34584889-33996E92-317C-4310-B822-0E13FDD5AC17Q34721095-E97E095A-182F-412D-B7C2-E57C4D53A7DEQ34738020-401D25C0-3BE5-4E72-8666-F3177E0E4E75Q35163360-7EAF891D-52D6-47E9-9021-3B21DC265936Q35557420-7FCD46FE-FB19-43EA-9A7F-ED9D94CFB397Q36025380-BD551A21-F710-4B89-B87D-2817F35A8BEEQ36591937-5ED8368B-47DF-47A3-AA80-57BE296F418FQ36767675-025AAD60-14D4-4227-B073-148AD27CBD48Q37306024-8DE4C22A-BC66-477F-9A54-8A2633131330Q37988188-6E690C1A-5F15-44B8-BDA4-3581C2E4E078Q40109190-4C6CC8A9-E2D3-4F14-B94B-14C2301A74D7Q42134625-5F998EBA-2094-4A56-8F31-C3DB9F538669Q43251106-AEAD810C-3F6F-4B62-8A98-A73289E71E6AQ43966274-048B4257-2459-4BA5-844B-C676E69E579DQ45170917-7FBB74E3-FE00-4318-916F-C376C36192ECQ54377329-5E9A4B67-9774-4EBE-A562-7220B41A1E1AQ54483273-319738D2-C489-4D95-BF8F-6615B88B1C04
P2860
Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-me
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@en
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@nl
type
label
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@en
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@nl
prefLabel
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@en
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@nl
P2093
P2860
P921
P356
P1476
Inhibition of lipopolysacchari ...... fluorophenyl)-4-(4-fluoro-2-me
@en
P2093
Chris L Clayton
Dave Singh
Lauren M Kent
Lucy J C Smyth
Steve M Fox
Stuart N Farrow
P2860
P304
P356
10.1124/JPET.108.142950
P407
P577
2008-11-12T00:00:00Z